ACDIMA

In the framework of Joint Arab action and in order to encourage the pharmaceutical industry, the Economic Unity Arab Council has adopted a decision on 6/3/1976 to establish an Arab institution that is capable of promoting this industry, which is the Arab Company for Drug Industries and Medical Appliances "ACDIMA", with a capital of (60) million Kuwaiti Dinars, that has been raised by the approval of the Extraordinary General Assembly held in Amman - Jordan on 10/10/2013 to (90) million Kuwaiti Dinars according to Riyadh Declaration for 2013, which approved the increase of the capital of joint Arab companies by at least 50%..

Acdima at glance

1976

Company Establishment

90M KWD

Capital Investment

150 employees

Number of employees

14 Companies

Affiliated Companies

10 Countries

Countries

47 Years

Experience

17 stakeholders

Number of stakeholders

“Our primary focus is Suport, manufacturing & marketing high quality products to meet the healthcare needs and elevate the quality of life in the arab word ”

ACDIMA Bio Center

ACDIMA Center for bioequivalence and pharmaceutical studies is a contract research organization based in Jordan. Established in 2000 to be one of the first BioCenters in Jordan with two decades of experience and more than 750 bioequivalence studies to produce top-notch pharmaceutical solutions around the world. With the increased demand for exceptional services, ACDIMA is striving to offer extraordinary outcomes to maintain and exceed its spot as one of the best bioequivalence centers, not only in Jordan, but in the whole region.

follow the link